Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa: A cross-sectional study

Research output: Contribution to journalLetterResearchpeer-review

Standard

Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa : A cross-sectional study. / Omari, N.; Simonsen, S.; Gluud, L. L.; Martin, H. M.; Trelle, M. B.; Jemec, G. B.; Skov, L.; Näslund-Koch, C.

In: Journal of the European Academy of Dermatology and Venereology, 2024.

Research output: Contribution to journalLetterResearchpeer-review

Harvard

Omari, N, Simonsen, S, Gluud, LL, Martin, HM, Trelle, MB, Jemec, GB, Skov, L & Näslund-Koch, C 2024, 'Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa: A cross-sectional study', Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.20110

APA

Omari, N., Simonsen, S., Gluud, L. L., Martin, H. M., Trelle, M. B., Jemec, G. B., Skov, L., & Näslund-Koch, C. (Accepted/In press). Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa: A cross-sectional study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.20110

Vancouver

Omari N, Simonsen S, Gluud LL, Martin HM, Trelle MB, Jemec GB et al. Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa: A cross-sectional study. Journal of the European Academy of Dermatology and Venereology. 2024. https://doi.org/10.1111/jdv.20110

Author

Omari, N. ; Simonsen, S. ; Gluud, L. L. ; Martin, H. M. ; Trelle, M. B. ; Jemec, G. B. ; Skov, L. ; Näslund-Koch, C. / Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa : A cross-sectional study. In: Journal of the European Academy of Dermatology and Venereology. 2024.

Bibtex

@article{b35839f9bdc14c2ab712642a63be317a,
title = "Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa: A cross-sectional study",
abstract = "Patients with hidradenitis suppurativa (HS) have higher prevalence of various concomitant disorders such as obesity, diabetes, metabolic syndrome and cardiovascular disease, compared to the general population.1 Recently, metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD),2 was added to the list.3 However, previous studies have focused on the presence of harmless liver steatosis rather on the presence of advanced fibrosis, which poses a greater clinical concern due to its high morbidity and mortality.4 In addition, previous studies lack data regarding important confounders such as alcohol consumption and severity of HS.",
author = "N. Omari and S. Simonsen and Gluud, {L. L.} and Martin, {H. M.} and Trelle, {M. B.} and Jemec, {G. B.} and L. Skov and C. N{\"a}slund-Koch",
note = "Funding Information: This study was supported by the Ellab Foundation, the LEO Foundation (grant number [LF\u2010ST\u201021\u2010500002]) and Copenhagen University Hospital \u2013 Herlev and Gentofte Hospital, Denmark. Siemens Healthcare provided the ELF test kits. ",
year = "2024",
doi = "10.1111/jdv.20110",
language = "English",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa

T2 - A cross-sectional study

AU - Omari, N.

AU - Simonsen, S.

AU - Gluud, L. L.

AU - Martin, H. M.

AU - Trelle, M. B.

AU - Jemec, G. B.

AU - Skov, L.

AU - Näslund-Koch, C.

N1 - Funding Information: This study was supported by the Ellab Foundation, the LEO Foundation (grant number [LF\u2010ST\u201021\u2010500002]) and Copenhagen University Hospital \u2013 Herlev and Gentofte Hospital, Denmark. Siemens Healthcare provided the ELF test kits.

PY - 2024

Y1 - 2024

N2 - Patients with hidradenitis suppurativa (HS) have higher prevalence of various concomitant disorders such as obesity, diabetes, metabolic syndrome and cardiovascular disease, compared to the general population.1 Recently, metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD),2 was added to the list.3 However, previous studies have focused on the presence of harmless liver steatosis rather on the presence of advanced fibrosis, which poses a greater clinical concern due to its high morbidity and mortality.4 In addition, previous studies lack data regarding important confounders such as alcohol consumption and severity of HS.

AB - Patients with hidradenitis suppurativa (HS) have higher prevalence of various concomitant disorders such as obesity, diabetes, metabolic syndrome and cardiovascular disease, compared to the general population.1 Recently, metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD),2 was added to the list.3 However, previous studies have focused on the presence of harmless liver steatosis rather on the presence of advanced fibrosis, which poses a greater clinical concern due to its high morbidity and mortality.4 In addition, previous studies lack data regarding important confounders such as alcohol consumption and severity of HS.

U2 - 10.1111/jdv.20110

DO - 10.1111/jdv.20110

M3 - Letter

C2 - 38764439

AN - SCOPUS:85193602333

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

ER -

ID: 393842739